Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 3;11(3):814.
doi: 10.3390/jcm11030814.

Motor-Independent Cognitive Testing in Motor Degenerative Diseases

Affiliations

Motor-Independent Cognitive Testing in Motor Degenerative Diseases

Henning Schmitz-Peiffer et al. J Clin Med. .

Abstract

Cognitive function is tested through speech- or writing-based neuropsychological instruments. The application and validity of those tests is impeded for patients with diseases that affect speech and hand motor skills. We therefore developed a "motor-free" gaze-controlled version of the Trail Making Test (TMT), including a calibration task to assess gaze accuracy, for completion by means of an eye-tracking computer system (ETCS). This electronic TMT version (eTMT) was evaluated for two paradigmatic "motor-neurodegenerative" diseases, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). We screened 146 subjects, of whom 44 were excluded, e.g., because of vision deficits. Patients were dichotomized into subgroups with less (ALS-, PD-) or severe motor affection (ALS+, PD+). All 66 patients and all 36 healthy controls (HC) completed the eTMT. Patients with sufficient hand motor control (ALS-, PD-, PD+) and all HC additionally completed the original paper-pencil-based version of the TMT. Sufficient and comparable gaze fixation accuracy across all groups and the correlations of the eTMT results with the TMT results supported the reliability and validity of the eTMT. PD+ patients made significantly more errors than HC in the eTMT-B. We hereby proved the good applicability of a motor-free cognitive test. Error rates could be a particularly sensitive marker of executive dysfunction.

Keywords: Parkinson’s disease; Trail Making Test; amyotrophic lateral sclerosis; cognition; executive functions; eye tracking; neuromuscular diseases; neuropsychological tests.

PubMed Disclaimer

Conflict of interest statement

H.S.-P., K.L., E.A., M.L., A.S., and A.H. declare no conflict of interest. W.R. and M.J.’s affiliation “Interactive Minds” is a provider of ETCS in the region of Dresden. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Flowchart of study enrollment for patients and healthy controls (HC).
Figure 2
Figure 2
Group comparisons and correlations for gaze accuracy and performance in TMT and eTMT. (a) Deviance (in degrees) between target and fixation in calibration task as measure of gaze accuracy; (b) correlation between written TMT-A and eTMT-A; (c) correlation between written TMT-B and eTMT-B; (d) completion times for eTMT subtests in comparison between groups; (e) B/A ratio of completion times for eTMT subtests in comparison between groups; (f) total number of errors in eTMT subtests in comparison between groups; (g) fixations per second in eTMT subtests in comparison between groups; (h) errors per fixation in eTMT subtests in comparison between groups. In figures (dh): ° outliers: values below the first quartile or above the third quartile with a distance of 1.5 to 3 times the interquartile range; * extreme outliers: values below the first quartile or above the third quartile with a distance of more than 3 times the interquartile range.

References

    1. Lakerveld J., Kotchoubey B., Kubler A. Cognitive function in patients with late stage amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2008;79:25–29. doi: 10.1136/jnnp.2007.116178. - DOI - PubMed
    1. Beeldman E., Raaphorst J., Twennaar M.K., De Visser M., Schmand B.A., De Haan R.J. The cognitive profile of ALS: A systematic review and meta-analysis update. J. Neurol. Neurosurg. Psychiatry. 2015;87:611–619. doi: 10.1136/jnnp-2015-310734. - DOI - PubMed
    1. Keller J., Krimly A., Bauer L., Schulenburg S., Böhm S., Aho-Özhan H.E.A., Uttner I., Gorges M., Kassubek J., Pinkhardt E.H., et al. A first approach to a neuropsychological screen-ing tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen. Amyotroph. Lateral Scler. Front. Degener. 2017;18:443–450. doi: 10.1080/21678421.2017.1313869. - DOI - PubMed
    1. BenBrika S., Desgranges B., Eustache F., Viader F. Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review. Front. Neurosci. 2019;13:951. doi: 10.3389/fnins.2019.00951. - DOI - PMC - PubMed
    1. Abrahams S., Newton J., Niven E., Foley J., Bak T.H. Screening for cognition and behaviour changes in ALS. Amyotroph. Lateral Scler. Front. Degener. 2013;15:9–14. doi: 10.3109/21678421.2013.805784. - DOI - PubMed

LinkOut - more resources